Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For BRM.DE
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Bad
0%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -22.20 1.11 1.43
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 49.49 10.81 7.23
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -43.72 8.15 14.48
Cash -20.91 4.78 6.04
Capex 13.56 -0.14 -0.16
Free Cash Flow -34.70 1.26 1.93
Revenue 3.83 5.87 5.65
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -1.04 0.75 0.76
Operating Margin 31.19 0.19 0.15
ROA 549.56 -0.12 0.02
ROE 1106.46 -0.72 0.06
ROIC 27.82 0.03 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of BRM.DE is permitted for members.
5 Growth
The "Growth Entry" for the Focus of BRM.DE is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of BRM.DE is permitted for members.